Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: Comparison with methylphenidate

Pharmacological Research

Volumn 62, Issue 6, 2010, Pages 523-529

  Fumagalli, Fabio ^a,b   Cattaneo, Annamaria ^c   Caffino, Lucia ^a   Ibba, Marcello ^d   Racagni, Giorgio ^a,b,c   Carboni, Ezio ^d   Gennarelli, Massimo ^c,e   Riva, Marco Andrea ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b Ctr of Excellence on Neurodeg Dis   (Italy)

^c IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^d UNIVERSITY OF CAGLIARI   (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Atomoxetine; Attention Deficit Hyperactivity Disorder; Brain derived neurotrophic factor; Methylphenidate

Indexed keywords

ATOMOXETINE; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; METHYLPHENIDATE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B;

ADOLESCENT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR CONTROL; BINDING AFFINITY; CAUDATE NUCLEUS; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ESSENTIAL HYPERTENSION; EXON; GENE EXPRESSION REGULATION; HIPPOCAMPUS; LONG TERM EXPOSURE; MALE; MOLECULAR MECHANICS; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; UPREGULATION;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CENTRAL NERVOUS SYSTEM STIMULANTS; HUMANS; MALE; METHYLPHENIDATE; PROPYLAMINES; RATS; RATS, INBRED SHR; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 78049527113     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2010.07.009     Document Type: Article

References (56)

1. Spencer T.J., Biederman J., Wilens T.E., Faraone S.V. Overview and neurobiology of attention-deficit/hyperactivity disorder. J Clin Psychiatry 2002, 63(Suppl. 12):3-9.
2. Adriani W., Caprioli A., Granstrem O., Carli M., Laviola G. The spontaneously hypertensive-rat as an animal model of adhd: evidence for impulsive and non-impulsive subpopulations. Neurosci Biobehav Rev 2003, 27:639-651.
3. Carboni E., Silvagni A., Valentini V., Di Chiara G. Effect of amphetamine, cocaine and depolarization by high potassium on extracellular dopamine in the nucleus accumbens shell of shr rats. An in vivo microdyalisis study. Neurosci Biobehav Rev 2003, 27:653-659.
4. Heal D.J., Smith S.L., Kulkarni R.S., Rowley H.L. New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of adhd. Pharmacol Biochem Behav 2008, 90:184-197.
5. Bymaster F.P., Katner J.S., Nelson D.L., Hemrick-Luecke S.K., Threlkeld P.G., Heiligenstein J.H., Morin S.M., Gehlert D.R., Perry K.W. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 2002, 27:699-711.
6. Adriani W., Laviola G. Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model. Behav Pharmacol 2004, 15:341-352.
7. Barron E., Yang P.B., Swann A.C., Dafny N. Adolescent and adult male spontaneous hyperactive rats (shr) respond differently to acute and chronic methylphenidate (ritalin). Int J Neurosci 2009, 119:40-58.
8. Vendruscolo L.F., Izidio G.S., Takahashi R.N., Ramos A. Chronic methylphenidate treatment during adolescence increases anxiety-related behaviors and ethanol drinking in adult spontaneously hypertensive rats. Behav Pharmacol 2008, 19:21-27.
9. Yang P.B., Swann A.C., Dafny N. Acute and chronic methylphenidate dose-response assessment on three adolescent male rat strains. Brain Res Bull 2006, 71:301-310.
10. Sotnikova T.D., Caron M.G., Gainetdinov R.R. Trace amine-associated receptors as emerging therapeutic targets. Mol Pharmacol 2009, 76:229-235.
11. Rios M., Fan G., Fekete C., Kelly J., Bates B., Kuehn R., Lechan R.M., Jaenisch R. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 2001, 15:1748-1757.
12. Gainetdinov R.R., Wetsel W.C., Jones S.R., Levin E.D., Jaber M., Caron M.G. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 1999, 283:397-401.
13. Fumagalli F., Racagni G., Colombo E., Riva M.A. Bdnf gene expression is reduced in the frontal cortex of dopamine transporter knockout mice. Mol Psychiatry 2003, 8:898-899.
14. Chapman R.H., Stern J.M. Maternal stress and pituitary-adrenal manipulations during pregnancy in rats: effects on morphology and sexual behavior of male offspring. J Comp Physiol Psychol 1978, 92:1074-1083.
15. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 2000, 24:417-463.
16. Molteni R., Calabrese F., Cattaneo A., Mancini M., Gennarelli M., Racagni G., Riva M.A. Acute stress responsiveness of the neurotrophin bdnf in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine. Neuropsychopharmacology 2009, 34:1523-1532.
17. Fumagalli F., Caffino L., Racagni G., Riva M.A. Repeated stress prevents cocaine-induced activation of bdnf signaling in rat prefrontal cortex. Eur Neuropsychopharmacol 2009, 19:402-408.
18. Arnsten A.F. Fundamentals of attention-deficit/hyperactivity disorder: Circuits and pathways. J Clin Psychiatry 2006, 67(Suppl. 8):7-12.
19. Tabuchi A., Sakaya H., Kisukeda T., Fushiki H., Tsuda M. Involvement of an upstream stimulatory factor as well as camp-responsive element-binding protein in the activation of brain-derived neurotrophic factor gene promoter i. J Biol Chem 2002, 277:35920-35931.
20. Takeuchi Y., Fukunaga K., Miyamoto E. Activation of nuclear ca(2+)/calmodulin-dependent protein kinase ii and brain-derived neurotrophic factor gene expression by stimulation of dopamine d2 receptor in transfected ng108-15 cells. J Neurochem 2002, 82:316-328.
21. Singer W., Panford-Walsh R., Watermann D., Hendrich O., Zimmermann U., Kopschall I., Rohbock K., Knipper M. Salicylate alters the expression of calcium response transcription factor 1 in the cochlea: implications for brain-derived neurotrophic factor transcriptional regulation. Mol Pharmacol 2008, 73:1085-1091.
22. Alessi D.R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., Hemmings B.A. Mechanism of activation of protein kinase b by insulin and igf-1. EMBO J 1996, 15:6541-6551.
23. Chen L., Salinas G.D., Li X. Regulation of serotonin 1b receptor by glycogen synthase kinase-3. Mol Pharmacol 2009, 76:1150-1161.
24. Arnsten A.F. Stimulants: therapeutic actions in adhd. Neuropsychopharmacology 2006, 31:2376-2383.
25. Aston-Jones G., Cohen J.D. Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance. J Comp Neurol 2005, 493:99-110.
26. Carboni E., Silvagni A. Experimental investigations on dopamine transmission can provide clues on the mechanism of the therapeutic effect of amphetamine and methylphenidate in adhd. Neural Plast 2004, 11:77-95.
27. Volkow N.D., Fowler J.S., Wang G.J. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. J Psychopharmacol 1999, 13:337-345.
28. Lanni C., Lenzken S.C., Pascale A., Del Vecchio I., Racchi M., Pistoia F., Govoni S. Cognition enhancers between treating and doping the mind. Pharmacol Res 2008, 57:196-213.
29. Repantis D., Schlattmann P., Laisney O., Heuser I. Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacol Res 2010, 62:187-206.
30. Koda K., Ago Y., Cong Y., Kita Y., Takuma K., Matsuda T. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice. J Neurochem 2010, 114:259-270.
31. Tsankova N.M., Berton O., Renthal W., Kumar A., Neve R.L., Nestler E.J. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 2006, 9:519-525.
32. Lackschewitz H., Huther G., Kroner-Herwig B. Physiological and psychological stress responses in adults with attention-deficit/hyperactivity disorder (adhd). Psychoneuroendocrinology 2008, 33:612-624.
33. Chase T., Carrey N., Soo E., Wilkinson M. Methylphenidate regulates activity regulated cytoskeletal associated but not brain-derived neurotrophic factor gene expression in the developing rat striatum. Neuroscience 2007, 144:969-984.
34. Banerjee P.S., Aston J., Khundakar A.A., Zetterstrom T.S. Differential regulation of psychostimulant-induced gene expression of brain derived neurotrophic factor and the immediate-early gene arc in the juvenile and adult brain. Eur J Neurosci 2009, 29:465-476.
35. Devilbiss D.M., Berridge C.W. Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness. Biol Psychiatry 2008, 64:626-635.
36. Zhu N., Weedon J., Dow-Edwards D.L. Oral methylphenidate improves spatial learning and memory in pre- and periadolescent rats. Behav Neurosci 2007, 121:1272-1279.
37. Arnsten A.F., Dudley A.G. Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine d1 receptor actions: relevance to therapeutic effects in attention deficit hyperactivity disorder. Behav Brain Funct 2005, 1:2.
38. Berridge C.W., Devilbiss D.M., Andrzejewski M.E., Arnsten A.F., Kelley A.E., Schmeichel B., Hamilton C., Spencer R.C. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 2006, 60:1111-1120.
39. Heyser C.J., Pelletier M., Ferris J.S. The effects of methylphenidate on novel object exploration in weanling and periadolescent rats. Ann N Y Acad Sci 2004, 1021:465-469.
40. LeBlanc-Duchin D., Taukulis H.K. Chronic oral methylphenidate administration to periadolescent rats yields prolonged impairment of memory for objects. Neurobiol Learn Mem 2007, 88:312-320.
41. LeBlanc-Duchin D., Taukulis H.K. Chronic oral methylphenidate induces post-treatment impairment in recognition and spatial memory in adult rats. Neurobiol Learn Mem 2009, 91:218-225.
42. Grimes C.A., Jope R.S. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 2001, 65:391-426.
43. Emamian E.S., Karayiorgou M., Gogos J.A. Decreased phosphorylation of nmda receptor type 1 at serine 897 in brains of patients with schizophrenia. J Neurosci 2004, 24:1561-1564.
44. Li X., Bijur G.N., Jope R.S. Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection. Bipolar Disord 2002, 4:137-144.
45. Li X., Rosborough K.M., Friedman A.B., Zhu W., Roth K.A. Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics. Int J Neuropsychopharmacol 2007, 10:7-19.
46. Calabrese F., Molteni R., Cattaneo A., Macchi F., Racagni G., Gennarelli M., et al. Long-term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms. Mol Pharmacol 2010, 77:846-853.
47. Bramham C.R., Messaoudi E. Bdnf function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 2005, 76:99-125.
48. Bolanos C.A., Barrot M., Berton O., Wallace-Black D., Nestler E.J. Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry 2003, 54:1317-1329.
49. Fumagalli F., Bedogni F., Perez J., Racagni G., Riva M.A. Corticostriatal brain-derived neurotrophic factor dysregulation in adult rats following prenatal stress. Eur J Neurosci 2004, 20:1348-1354.
50. Roceri M., Cirulli F., Pessina C., Peretto P., Racagni G., Riva M.A. Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions. Biol Psychiatry 2004, 55:708-714.
51. Fumagalli F., Molteni R., Racagni G., Riva M.A. Stress during development: impact on neuroplasticity and relevance to psychopathology. Prog Neurobiol 2007, 81:197-217.
52. Polter A., Beurel E., Yang S., Garner R., Song L., Miller C.A., et al. Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances. Neuropsychopharmacology 2010, 35:1761-1774.
53. Eisch A.J., Bolanos C.A., de Wit J., Simonak R.D., Pudiak C.M., Barrot M., Verhaagen J., Nestler E.J. Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biol Psychiatry 2003, 54:994-1005.
54. Kratochvil C.J., Milton D.R., Vaughan B.S., Greenhill L.L. Acute atomoxetine treatment of younger and older children with adhd: a meta-analysis of tolerability and efficacy. Child Adolesc Psychiatry Ment Health 2008, 2:25.
55. Chou W.J., Chou M.C., Tzang R.F., Hsu Y.C., Gau S.S., Chen S.J., Wu Y.Y., Huang Y.F., Liang H.Y., Cheng H. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three adhd subtypes. Psychiatry Clin Neurosci 2009, 63:167-175.
56. Sakata K, Jin L, Jha S. Lack of promoter iv-driven bdnf transcription results in depression-like behavior. Genes Brain Behav 2010. [Epub ahead of print] logical research.